SCHEMBL796966

SCHEMBL796966

CCCOc1ccc2c(c1)sc1nc(-c3ccc(NC)cc3)cn12

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.83
LMNA P02545 3/20 0.55
TP53 P04637 3/20 0.55
MAPT P10636 3/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
TSHR P16473 1/20 0.55
RAB9A P51151 1/20 0.55
ATM Q13315 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
RXFP1 Q9HBX9 1/20 0.54
FLT3 P36888 8/20 0.51
KDR P35968 2/20 0.49
BMPR1B O00238 1/20 0.49
MUSK O15146 1/20 0.49
EPHB6 O15197 1/20 0.49
MAP3K7 O43318 1/20 0.49
RIPK2 O43353 1/20 0.49
PAK3 O75914 1/20 0.49
STK10 O94804 1/20 0.49
MAP4K4 O95819 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10067623 0.92 APP (0.86) APPLMNATP53MAPTSMN1; SMN2
SCHEMBL772879 0.91 APP (1.00) APPLMNATP53MAPTSMN1; SMN2
SCHEMBL796995 0.91 APP (1.00) APPLMNATP53MAPTSMN1; SMN2
SCHEMBL24757674 0.91 APP (0.81) APPLMNATP53MAPTSMN1; SMN2
SCHEMBL24758467 0.90 APP (0.77) APPLMNATP53MAPTSMN1; SMN2
SCHEMBL804632 0.90 APP (0.90) APPLMNATP53MAPTSMN1; SMN2
SCHEMBL805073 0.88 APP (0.85) APPLMNATP53MAPTSMN1; SMN2
SCHEMBL10067593 0.87 APP (0.82) APPLMNATP53MAPTSMN1; SMN2
SCHEMBL10067594 0.87 APP (0.89) APPLMNATP53MAPTSMN1; SMN2
SCHEMBL804634 0.87 APP (0.89) APPLMNATP53MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides TECHNISCHE UNIVERSITAT MUNCHEN (DE) 2012-03-22 US disclosed
WO-2010092111-A2 COMPOUNDS FOR NON-INVASIVE MEASUREMENT OF AGGREGATES OF AMYLOID PEPTIDES Technische Universität München (DE) 2010-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides IAPP, APP, HTT APP 2/4885LMNA 1196/4885TP53 619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.